Nystaform-HC

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

82 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 9 EU WC, 10 KDMF, 39 NDC API, 1 VMF, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

FINISHED DOSAGE FORMULATIONS

587 FDF Dossiers, 237 FDA Orange Book, 281 Europe, 11 Canada, 8 Australia, 28 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, LOTION;TOPICAL - 2%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 8 SPI Pharma, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 Pfanstiehl, 23 Kirsch Pharma, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 4 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Esteem Industries, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 2 Ideal Cures, 4 Ingredion Pharma Solutions, 19 Kerry, 3 Keval Exports, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

83 Topical, 60 Thickeners and Stabilizers, 59 Solubilizers, 55 Parenteral, 51 Fillers, Diluents & Binders, 36 Direct Compression, 33 Granulation, 32 Emulsifying Agents, 27 Disintegrants & Superdisintegrants, 25 Coating Systems & Additives, 23 Controlled & Modified Release, 23 Lubricants & Glidants, 23 Surfactant & Foaming Agents, 20 Film Formers & Plasticizers, 18 Taste Masking, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 7 Rheology Modifiers, 6 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 53 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 54 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

38 APIs, 17 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 1 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 JP, 27 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Nystaform-HC

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Nystaform-HC? Find Coloring Agents used in Nystaform-HC to address drug delivery challenges on PharmaCompass.

Nystaform-HC

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

82 API Suppliers

29 USDMF

14 CEP/COS

6 JDMF

9 EU WC

10 KDMF

39 NDC API

1 VMF

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

FINISHED DOSAGE FORMULATIONS

587 FDF Dossiers

237 FDA Orange Book

281 Europe

11 Canada

8 Australia

28 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

LOTION;TOPICAL - 2%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

8 SPI Pharma

1 Pharm-RX Chemical

6 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

4 Pfanstiehl

23 Kirsch Pharma

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

4 CD Formulation

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Esteem Industries

6 Finar

16 Gangwal Chemicals

2 Hayashibara

2 Ideal Cures

4 Ingredion Pharma Solutions

19 Kerry

3 Keval Exports

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

5 Silverline Chemicals

1 Symrise

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons